Lifecore Biomedical Inc. (LFCR) - Total Liabilities
Based on the latest financial reports, Lifecore Biomedical Inc. (LFCR) has total liabilities worth $198.42 Million USD as of August 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Lifecore Biomedical Inc. generate cash to assess how effectively this company generates cash.
Lifecore Biomedical Inc. - Total Liabilities Trend (1996–2025)
This chart illustrates how Lifecore Biomedical Inc.'s total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Lifecore Biomedical Inc. to evaluate the company's liquid asset resilience ratio.
Lifecore Biomedical Inc. Competitors by Total Liabilities
The table below lists competitors of Lifecore Biomedical Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Latécoère S.A.
PA:LAT
|
France | €556.13 Million |
|
Aluko Co Ltd
KO:001780
|
Korea | ₩527.00 Billion |
|
Amber International Holding Limited
NASDAQ:AMBR
|
USA | $201.71 Million |
|
Hindware Home Innovation Limited
NSE:HINDWAREAP
|
India | Rs17.69 Billion |
|
Matba Rofex SA
BA:MTR
|
Argentina | AR$166.74 Billion |
|
Saraswanti Anugerah Makmur Pt
JK:SAMF
|
Indonesia | Rp1.66 Trillion |
|
Willow Lane Acquisition Corp. Class A Ordinary Shares
NASDAQ:WLAC
|
USA | $4.52 Million |
Liability Composition Analysis (1996–2025)
This chart breaks down Lifecore Biomedical Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Lifecore Biomedical Inc. (LFCR) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 5.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.84 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lifecore Biomedical Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lifecore Biomedical Inc. (1996–2025)
The table below shows the annual total liabilities of Lifecore Biomedical Inc. from 1996 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-05-31 | $238.01 Million | -1.91% |
| 2024-05-31 | $242.65 Million | +29.84% |
| 2023-05-31 | $186.88 Million | -0.18% |
| 2022-05-31 | $187.22 Million | -37.62% |
| 2021-05-31 | $300.14 Million | -3.26% |
| 2020-05-31 | $310.27 Million | +24.63% |
| 2019-05-31 | $248.95 Million | +63.63% |
| 2018-05-31 | $152.14 Million | +17.16% |
| 2017-05-31 | $129.86 Million | -0.96% |
| 2016-05-31 | $131.12 Million | +3.77% |
| 2015-05-31 | $126.36 Million | +16.07% |
| 2014-05-31 | $108.86 Million | -1.51% |
| 2013-05-31 | $110.53 Million | -12.37% |
| 2012-05-31 | $126.13 Million | +83.91% |
| 2011-05-31 | $68.59 Million | +1.28% |
| 2010-05-31 | $67.72 Million | +163.82% |
| 2009-05-31 | $25.67 Million | -25.75% |
| 2008-05-31 | $34.57 Million | +18.02% |
| 2007-05-31 | $29.30 Million | -9.04% |
| 2006-05-31 | $32.20 Million | +21.30% |
| 2005-05-31 | $26.55 Million | -11.23% |
| 2004-05-31 | $29.91 Million | -20.40% |
| 2003-05-31 | $37.57 Million | -25.25% |
| 2002-05-31 | $50.26 Million | -27.42% |
| 2001-05-31 | $69.25 Million | +3.77% |
| 2000-05-31 | $66.73 Million | +649.82% |
| 1999-05-31 | $8.90 Million | +2.30% |
| 1998-05-31 | $8.70 Million | -40.41% |
| 1997-05-31 | $14.60 Million | +711.11% |
| 1996-05-31 | $1.80 Million | -- |
About Lifecore Biomedical Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It offers services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device pr… Read more